Skip to content

Research on the effects and biological mechanisms of repetitive transcranial magnetic stimulation on post-stroke cognitive impairment from a multi-omics perspective

Research on the effects and biological mechanisms of repetitive transcranial magnetic stimulation on post-stroke cognitive impairment from a multi-omics perspective

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102485
Enrollment
Unknown
Registered
2025-05-15
Start date
2025-07-18
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke,Cognitive impairment

Interventions

True Stimulus Group:Receiving rTMS DLPFC true stimulation on the affected side
Pseudostimulus group:Acceptance of rTMS affected side DLPFC pseudostimulation

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In accordance with the diagnostic criteria for stroke in the "Guidelines for the Prevention and Treatment of Stroke in China (2021 Edition)," confirmed by cranial CT or magnetic resonance imaging; 2. Mini-Mental State Examination score: illiterate <= 17 points, primary school = 20 points, junior high school and above <=24 points; Montreal Cognitive Assessment score < 26 points. 3. Stable vital signs; 4. Informed consent, voluntary participation, informed consent form signed by the subject and their guardian.

Exclusion criteria

Exclusion criteria: 1. Individuals with consciousness disorders; those with severe hearing and visual impairments and inability to cooperate due to aphasia; individuals with immune system diseases, blood system diseases, and organ failure. 2. Subjects unable to cooperate in completing treatment due to other reasons. 3. Presence of contraindications for transcranial magnetic stimulation, such as intracranial metal implants, pacemakers, or a history of seizures. 4. Use of antibiotics or anti-inflammatory medications in the past month, and having taken probiotics in the past two months. 5. Participation in other clinical trials that may affect the final evaluation results of this trial.

Design outcomes

Primary

MeasureTime frame
EEG change;Brain function;

Secondary

MeasureTime frame
Mental status ;Cognition;Modified Barthel Index;Brain structure;

Countries

China

Contacts

Public ContactZuoyan Liu

West China Hospital of Sichuan University

522827400@qq.com+86 189 8060 6071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026